This study is a phase I trial to investigate the effect of inhibition of CYP3A4/5 by Erythromycin on the research hub

Effect of Erythromycin on the absorption, metabolism and elimination of CHF6001 in healthy volunteers

This study looks at how a common antibiotic, erythromycin, might change how a new medicine, CHF6001, works in the body. Researchers want to see if erythromycin affects how much of CHF6001 gets into the body, how it's used, and how it leaves the body.